Hookipa Net Debt from 2010 to 2024

HOOK Stock

USD 2.30 0.42 15.44%

Hookipa Pharma Net Debt yearly trend continues to be quite stable with very little volatility. The value of Net Debt is projected to decrease to about -116.1 M. Net Debt is the total debt of Hookipa Pharma minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2018-12-31

Previous Quarter

-72.3 M

Current Value

-56.9 M

Quarterly Volatility

25.6 M

Covid

Check Hookipa Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hookipa Pharma's main balance sheet or income statement drivers, such as Tax Provision of 454.6 K, Net Interest Income of 4.8 M or Interest Income of 5.2 M, as well as many indicators such as Price To Sales Ratio of 3.61, Dividend Yield of 0.0 or PTB Ratio of 0.81. Hookipa financial statements analysis is a perfect complement when working with Hookipa Pharma Valuation or Volatility modules.

Check out the analysis of Hookipa Pharma Correlation against competitors.

For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.

Latest Hookipa Pharma's Net Debt Growth Pattern

Below is the plot of the Net Debt of Hookipa Pharma over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Hookipa Pharma's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hookipa Pharma's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Hookipa Net Debt Regression Statistics

	Arithmetic Mean	(75,348,590)
	Coefficient Of Variation	(38.48)
	Mean Deviation	25,602,520
	Median	(57,624,000)
	Standard Deviation	28,991,615
	Sample Variance	840.5T
	Range	88.5M
	R-Value	(0.70)
	Mean Square Error	462.5T
	R-Squared	0.49
	Significance	0
	Slope	(4,533,378)
	Total Sum of Squares	11767.2T

Hookipa Net Debt History

	2024	-116.1 M
	2023	-110.5 M
	2022	-106.9 M
	2021	-56.3 M
	2020	-132.7 M
	2019	-102.6 M
	2018	-44.2 M

Other Fundumenentals of Hookipa Pharma

Net Debt To E B I T D A

Hookipa Pharma Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Long Term Debt Total	Capital Surpluse	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Property Plant Equipment	Capital Stock	Common Stock	Short Long Term Debt	Short Term Debt
Total Assets		0.93	0.98	0.73	-0.94	-0.8	0.74	-0.58	0.91	-0.56	0.94	-0.69	0.92	0.99	0.94	0.93	0.63	0.63	0.54	0.68
Total Stockholder Equity	0.93		0.93	0.71	-0.81	-0.72	0.71	-0.45	0.83	-0.42	0.87	-0.91	1.0	0.9	0.83	0.89	0.53	0.53	0.58	0.61
Net Tangible Assets	0.98	0.93		0.66	-0.88	-0.75	0.73	-0.53	0.89	-0.5	0.94	-0.72	0.93	0.96	0.91	0.94	0.57	0.57	0.59	0.65
Current Deferred Revenue	0.73	0.71	0.66		-0.6	-0.87	0.77	-0.79	0.77	-0.79	0.85	-0.57	0.7	0.7	0.5	0.83	0.73	0.73	0.17	0.86
Net Debt	-0.94	-0.81	-0.88	-0.6		0.72	-0.6	0.51	-0.75	0.48	-0.8	0.56	-0.81	-0.96	-0.97	-0.78	-0.68	-0.68	-0.33	-0.5
Retained Earnings	-0.8	-0.72	-0.75	-0.87	0.72		-0.85	0.92	-0.85	0.91	-0.89	0.54	-0.71	-0.77	-0.6	-0.88	-0.92	-0.92	-0.26	-0.92
Accounts Payable	0.74	0.71	0.73	0.77	-0.6	-0.85		-0.64	0.85	-0.65	0.86	-0.56	0.71	0.73	0.56	0.83	0.71	0.71	0.52	0.79
Long Term Debt	-0.58	-0.45	-0.53	-0.79	0.51	0.92	-0.64		-0.68	1.0	-0.73	0.27	-0.44	-0.54	-0.36	-0.73	-0.86	-0.86	-0.01	-0.91
Net Receivables	0.91	0.83	0.89	0.77	-0.75	-0.85	0.85	-0.68		-0.68	0.95	-0.6	0.82	0.88	0.76	0.92	0.61	0.61	0.68	0.86
Long Term Debt Total	-0.56	-0.42	-0.5	-0.79	0.48	0.91	-0.65	1.0	-0.68		-0.71	0.24	-0.41	-0.52	-0.33	-0.71	-0.86	-0.86	-0.02	-0.92
Capital Surpluse	0.94	0.87	0.94	0.85	-0.8	-0.89	0.86	-0.73	0.95	-0.71		-0.64	0.87	0.92	0.78	0.99	0.69	0.69	0.49	0.85
Total Liab	-0.69	-0.91	-0.72	-0.57	0.56	0.54	-0.56	0.27	-0.6	0.24	-0.64		-0.91	-0.65	-0.57	-0.69	-0.38	-0.38	-0.52	-0.43
Net Invested Capital	0.92	1.0	0.93	0.7	-0.81	-0.71	0.71	-0.44	0.82	-0.41	0.87	-0.91		0.9	0.83	0.88	0.52	0.52	0.59	0.6
Total Current Assets	0.99	0.9	0.96	0.7	-0.96	-0.77	0.73	-0.54	0.88	-0.52	0.92	-0.65	0.9		0.96	0.9	0.64	0.64	0.5	0.63
Net Working Capital	0.94	0.83	0.91	0.5	-0.97	-0.6	0.56	-0.36	0.76	-0.33	0.78	-0.57	0.83	0.96		0.76	0.5	0.5	0.49	0.43
Property Plant Equipment	0.93	0.89	0.94	0.83	-0.78	-0.88	0.83	-0.73	0.92	-0.71	0.99	-0.69	0.88	0.9	0.76		0.69	0.69	0.46	0.83
Capital Stock	0.63	0.53	0.57	0.73	-0.68	-0.92	0.71	-0.86	0.61	-0.86	0.69	-0.38	0.52	0.64	0.5	0.69		1.0	-0.04	0.72
Common Stock	0.63	0.53	0.57	0.73	-0.68	-0.92	0.71	-0.86	0.61	-0.86	0.69	-0.38	0.52	0.64	0.5	0.69	1.0		-0.04	0.72
Short Long Term Debt	0.54	0.58	0.59	0.17	-0.33	-0.26	0.52	-0.01	0.68	-0.02	0.49	-0.52	0.59	0.5	0.49	0.46	-0.04	-0.04		0.36
Short Term Debt	0.68	0.61	0.65	0.86	-0.5	-0.92	0.79	-0.91	0.86	-0.92	0.85	-0.43	0.6	0.63	0.43	0.83	0.72	0.72	0.36

Click cells to compare fundamentals

About Hookipa Pharma Financial Statements

Hookipa Pharma investors utilize fundamental indicators, such as Net Debt, to predict how Hookipa Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	-110.5 M	-116.1 M
Net Debt To EBITDA	1.43	2.71

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Hookipa Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Hookipa Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Hookipa Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Hookipa Pharma Stock:

How To Invest In Hookipa

Details

Is Hookipa Stock a good investment?

Details

What is Hookipa Pharma's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Hookipa Pharma Correlation against competitors.

For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.

You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.67)

Revenue Per Share

4.403

Quarterly Revenue Growth

(0.52)

Return On Assets

(0.20)

Return On Equity

(0.49)

The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Hookipa Net Debt from 2010 to 2024

Latest Hookipa Pharma's Net Debt Growth Pattern

Hookipa Net Debt Regression Statistics

Hookipa Net Debt History

Other Fundumenentals of Hookipa Pharma

Hookipa Pharma Net Debt component correlations

About Hookipa Pharma Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY